Skip to content

The Effect of Bilateral Infraorbital and Infratrochlear Nerve Block on Perioperative Period of Hypophysectomy

The Effect of Bilateral Infraorbital and Infratrochlear Nerve Block on Perioperative Analgesia After Endoscopic Binostril Transnasal Transsphenoidal Resection of Pituitary: a Prospective, Randomized Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05555147
Enrollment
120
Registered
2022-09-26
Start date
2022-09-01
Completion date
2023-09-28
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Block, Pain

Brief summary

The endoscopic binostril transnasal transsphenoidal resection of pituitary procedures often cause intense pain which is difficult to suppress at the depth of conventional general anesthesia, resulting in severe hemodynamic fluctuations in patients. Infraorbital and infratrochlear nerve block can block the pain signal caused by the endoscopic binostril transnasal transsphenoidal resection of pituitary theoretically, which has been proven to provide satisfactory analgesia after septorhinoplasty. However, whether bilateral infraorbital and infratrochlear nerve block can provide stable hemodynamics and reduce the hemodynamic fluctuation the patients undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary remains unclear.

Detailed description

Surgical stimulation is one of the important factors leading to hemodynamic fluctuation and affecting postoperative recovery quality. The endoscopic binostril transnasal transsphenoidal resection of pituitary procedures often cause intense pain because of there were numerous nerve endings at the surgical site which is originated from branches of the trigeminal nerve (including infraorbital and infratrochlear nerve). It's difficult to suppress intraoperative stimulation at the depth of conventional general anesthesia, resulting in severe hemodynamic fluctuations in patients. It's reported that pterygomaxillary fossa block can inhibit hypertension caused by surgical procedures, however the block may cause complications because of its complicated operations. Infraorbital and infratrochlear nerve block can block the pain signal caused by the endoscopic binostril transnasal transsphenoidal resection of pituitary theoretically, which has been proven to provide satisfactory analgesia after septorhinoplasty. However, whether bilateral infraorbital and infratrochlear nerve block can reduce the pain in the patients undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary remains unclear. Therefore, the investigators propose the hypothesis that preoperative bilateral infraorbital and infratrochlear nerve block could effectively reduce the pain in patients undergoing endoscopic binostril transnasal transsphenoidal resection of pituitary. The objective of this study is to observe the heart rate and blood pressure at a specific point in time during the operation and pain at 2, 8, 24, 48 hours postoperatively between adult patients receiving or not receiving bilateral infraorbital and infratrochlear nerve block.

Interventions

After general anesthesia, the patients will receive bilateral infraorbital and infratrochlear nerve block 30 minutes prior to surgery. Infraorbital nerve block is performed while using an extraoral approach. A 25-gauge needle was inserted laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. The index finger of the non-dominant hand was positioned above the infraorbital foramen, and the needle was advanced until it was felt beneath the finger. 2 ml of the 0.5% ropivacaine slowly injected after negative aspiration of blood was confirmed. Inserting the needle 1 cm above the inner canthus, targeting the junction of the orbit and the nasal bone, performed infratrochlear nerve block. After negative aspiration of blood, 1 ml of the 0.5% ropivacaine was injected. Contralateral nerve block was performed in the same manner.

OTHERwithout any nerve block

Patients receiving general anesthesia without Infraorbital and Infratrochlear nerve block.

Sponsors

Tongji Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Masking description

The patients were randomly assigned to one of two groups by a single nurse, who was not involved in the anesthetic management of the patient, while using a computer-generated randomization sequence with random block sizes of two and four. The same nurse prepared syringes containing the nerve block solution. Syringes for the block group (Block group) were filled with 6 mL of 0.5% ropivacaine. The patient, surgeon,and investigator were all blinded to the study and the adequacy of the block.

Intervention model description

Thirty minutes prior to surgery the patients received bilateral infraorbital and infratrochlear nerve block. The patient's head was positioned on a central line in the supine position. A 25 gauge needle was inserted laterally to the ipsilateral nostril after palpating the infraorbital ridge to locate the infraorbital foramen. The index finger of the non-dominant hand was positioned above the infraorbital foramen, and the needle was advanced until it was felt beneath the finger . 2 mL of the study solution was slowly injected after negative aspiration of blood was confirmed. Inserting the needle 1 cm above the inner canthus, targeting the junction of the orbit and the nasal bone, performed Infratrochlear nerve block. After negative aspiration of blood, 1 mL of the study solution was injected. Contralateral nerve block was performed in the same manner.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Elective endoscopic binostril transnasal transsphenoidal resection * 2\. Patients aged between 18 and 65. * 3\. American Society of Anesthesiologists (ASA) physical status I, Ⅱ and III

Exclusion criteria

* 1\. Emergency operation. * 2\. Patients allergic to ropivacaine. * 3\. Infection nearby the puncture point. * 4\. Patients with preoperative usage of sedative and analgesic drugs with history of alcohol abuse. * 5\. Patient with renal insufficiency or hepatic failure. * 6\. Patients who have undergone craniotomy in the recent 6 months. * 7\. Pregnant or lactating women, being participating in other studies. * 8\. Patients unable to cooperate.

Design outcomes

Primary

MeasureTime frameDescription
HR immediately after exploration of pituitary fossaimmediately after exploration of pituitary fossaHR immediately after exploration of pituitary fossa
MAP immediately after exploration of pituitary fossaimmediately after exploration of pituitary fossaMAP immediately after exploration of pituitary fossa
HR before exploration of pituitary fossabefore exploration of pituitary fossaHR before exploration of pituitary fossa
MAP before exploration of pituitary fossabefore exploration of pituitary fossaMAP before exploration of pituitary fossa
MAP within 10 minutes after nerve blockwithin 10 minutes after nerve blockMAP within 10 minutes after nerve block
HR immediately after dural incision of sellaimmediately after dural incision of sellaHR immediately after dural incision of sella
MAP immediately after dural incision of sellaimmediately after dural incision of sellaMAP immediately after dural incision of sella
HR before dural incision of sellabefore dural incision of sellaHR before dural incision of sella
MAP before dural incision of sellabefore dural incision of sellaMAP before dural incision of sella
HR immediately after sella bone resectionimmediately after sella bone resectionHR immediately after sella bone resection
MAP after sella bone resectionbefore sella bone resectionMAP after sella bone resection
HR before sella bone resectionbefore sella bone resectionHR before sella bone resection
MAP before sella bone resectionbefore sella bone resectionMAP before sella bone resection
HR immediately after septum resectionimmediately after septum resectionHR immediately after septum resection
MAP immediately after septum resectionimmediately after septum resectionMAP immediately after septum resection
HR before septum resectionbefore septum resectionHR before septum resection
MAP before septum resectionbefore septum resectionMAP before septum resection
HR immediately after nasal mucosal dissectionimmediately after nasal mucosal dissectionHR immediately after nasal mucosal dissection
MAP immediately after nasal mucosal dissectionimmediately after nasal mucosal dissectionMAP immediately after nasal mucosal dissection
HR before nasal mucosal dissectionbefore nasal mucosal dissectionHR before nasal mucosal dissection
MAP before nasal mucosal dissectionbefore nasal mucosal dissectionMAP before nasal mucosal dissection
HR within 10 minutes after nerve blockwithin 10 minutes after nerve blockHR within 10 minutes after nerve block
heat rate (HR) before nerve blockbefore nerve blockheat rate (HR) before nerve block
mean arterial pressure (MAP) before nerve blockbefore nerve blockmean arterial pressure (MAP) before nerve block

Secondary

MeasureTime frameDescription
NRS 8 hours after surgery8 hours after surgeryNRS 8 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method.
quality of recovery Scale: Quality of Recovery-15 (QoR-15) 1 day after surgery1 day after surgeryquality of recovery Scale (QoR-15): QoR-15 1 day after surgery. QoR-15 contains the five aspects (physiological comfort, physiological independence, psychological support, emotion and pain), which can evaluate postoperative recovery quality.
numerical rating scale (NRS) score when patient enters post-anaesthesia care unit (PACU) (immediately after surgery)when patient enters PACU (immediately after surgery)numerical rating scale (NRS) score when patient enters PACU (immediately after surgery). The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method.
numerical rating scale (NRS) score before patient leaves PACUbefore patient leaves PACUnumerical rating scale (NRS) score before patient leaves PACU. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method.
NRS 2 hours after surgery2 hours after surgeryNRS 2 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method.
NRS 24 hours after surgery24 hours after surgeryNRS 24 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method.
NRS 48 hours after surgery48 hours after surgeryNRS 48 hours after surgery. The participants subjectively determine the patient's pain scores using a 0 to 10 NRS (0 = no pain; 10 = unbearable pain), to evaluate the efficacy of the modified method.
quality of recovery Scale: QoR-15 3 days after surgery3 days after surgeryquality of recovery Scale: QoR-15 3 days after surgery. QoR-15 contains the five aspects (physiological comfort, physiological independence, psychological support, emotion and pain), which can evaluate postoperative recovery quality.
quality of recovery Scale: QoR-15 7 days after surgery7 days after surgeryquality of recovery Scale: QoR-15 7 days after surgery. QoR-15 contains the five aspects (physiological comfort, physiological independence, psychological support, emotion and pain), which can evaluate postoperative recovery quality.

Other

MeasureTime frameDescription
incidence of postoperative nausea and vomiting (PONV) within 24 hourswithin 24h after surgerywithin 24 hours after surgery, the investigators record the number of patients who suffer from PONV, and then calculate the incidence as: the number of patient suffering from PONV/the total number in corresponding group
incidence of local anesthetic toxicity in both two groups within 24 hourswithin 24 hours after surgerywithin 24 hours after operation, the investigators record the number of patients who suffer from local anesthetic toxicity, and then calculate the incidence as: the number of patient suffering from local anesthetic toxicity/the total number in corresponding group
incidence of infection at the block point in both two groups within 24 hourswithin 24 hours after surgerywithin 24 hours after operation, the investigators record the number of patients who suffer from infection at the block point, and then calculate the incidence as: the number of patient suffering from infection at the block point/the total number in corresponding group
incidence of hematoma at the block point in both two groups within 24 hourswithin 24 hours after surgerywithin 24 hours after operation, the investigators record the number of patients who suffer from hematoma at the block point, and then calculate the incidence as: the number of patient suffering from hematoma at the block point/the total number in corresponding group
the dosage of remedial antiemetics within 48 hourswithin 48 hours after surgerythe dosage of remedial antiemetics within 48 hours after surgery
the time of initial administration of remedial antiemetics within 48 hourswithin 48 hours after surgerythe time of initial administration of remedial antiemetics within 48 hours after surgery
the dosage of remedial esmololduring surgerythe dosage of remedial esmolol during surgery
the dosage of remedial perdipineduring surgerythe dosage of remedial perdipine during surgery
the dosage of remedial painkillers (remifentanil)during surgerythe dosage of remedial painkillers (remifentanil) during surgery
maintenance infusion rate of remifentanilduring surgeryinfusion rate of remifentanil for maintaining effective analgesic effect during surgery
bleeding volumeduring surgerybleeding volume during surgery
urine volumeduring surgeryurine volume during surgery
anesthetic dosageduring surgeryuse dosage of anesthetic drug during operation
PACU staying timefrom the time of patient coming in PACU until the time of patient coming out PACUtime from the time of patient coming in PACU until the time of patient coming out PACU
awakening timefrom the time of anesthesia end until the time of patient awakenfrom the time of anesthesia end until the time of patient awaken
anesthesia timefrom the time of anesthesia beginning until end time of anesthesiafrom the time of anesthesia beginning until end time of anesthesia
operation timefrom the time of surgery beginning until end time of surgeryfrom the time of surgery beginning until end time of surgery
Ramsay sedation scale (RSS) 48 hours after surgery48 hours after surgeryRamsay sedation scale (RSS) 48 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation).
Ramsay sedation scale (RSS) 24 hours after surgery24 hours after surgeryRamsay sedation scale (RSS) 24 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation).
Ramsay sedation scale (RSS) 8 hours after surgery8 hours after surgeryRamsay sedation scale (RSS) 8 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation).
Ramsay sedation scale (RSS) 2 hours after surgery2 hours after surgeryRamsay sedation scale (RSS) 2 hours after surgery. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation).
Ramsay sedation scale (RSS) before patient leaves PACUbefore patient leaves PACURamsay sedation scale (RSS) before patient leaves PACU. The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation).
Ramsay sedation scale (RSS) when patient enters PACU (immediately after surgery)when patient enters PACU (immediately after surgery)Ramsay sedation scale (RSS) when patient enters PACU (immediately after surgery). The participants subjectively determine the patient's sedation scores using a 1 to 6 RSS (1=fidgety, 2-4=sedation satisfaction, 5-6=excessive sedation).
incidence of postoperative nausea and vomiting (PONV) within 48 hourswithin 48 hours after surgerywithin 48 hours after surgery, the investigators record the number of patients who suffer from PONV, and then calculate the incidence as: the number of patient suffering from PONV/the total number in corresponding group

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026